Appropriate use of nevirapine for long-term therapy.
Publication
, Journal Article
Leith, J; Piliero, P; Storfer, S; Mayers, D; Hinzmann, R
Published in: J Infect Dis
August 1, 2005
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Infect Dis
DOI
ISSN
0022-1899
Publication Date
August 1, 2005
Volume
192
Issue
3
Start / End Page
545 / 546
Location
United States
Related Subject Headings
- Reverse Transcriptase Inhibitors
- Nevirapine
- Microbiology
- Liver
- Humans
- HIV-1
- HIV Infections
- CD4 Lymphocyte Count
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Leith, J., Piliero, P., Storfer, S., Mayers, D., & Hinzmann, R. (2005). Appropriate use of nevirapine for long-term therapy. J Infect Dis, 192(3), 545–546. https://doi.org/10.1086/431606
Leith, Jonathan, Peter Piliero, Stephen Storfer, Douglas Mayers, and Ralf Hinzmann. “Appropriate use of nevirapine for long-term therapy.” J Infect Dis 192, no. 3 (August 1, 2005): 545–46. https://doi.org/10.1086/431606.
Leith J, Piliero P, Storfer S, Mayers D, Hinzmann R. Appropriate use of nevirapine for long-term therapy. J Infect Dis. 2005 Aug 1;192(3):545–6.
Leith, Jonathan, et al. “Appropriate use of nevirapine for long-term therapy.” J Infect Dis, vol. 192, no. 3, Aug. 2005, pp. 545–46. Pubmed, doi:10.1086/431606.
Leith J, Piliero P, Storfer S, Mayers D, Hinzmann R. Appropriate use of nevirapine for long-term therapy. J Infect Dis. 2005 Aug 1;192(3):545–546.
Published In
J Infect Dis
DOI
ISSN
0022-1899
Publication Date
August 1, 2005
Volume
192
Issue
3
Start / End Page
545 / 546
Location
United States
Related Subject Headings
- Reverse Transcriptase Inhibitors
- Nevirapine
- Microbiology
- Liver
- Humans
- HIV-1
- HIV Infections
- CD4 Lymphocyte Count
- 42 Health sciences
- 32 Biomedical and clinical sciences